Serum 25(OH)D may serve as a biomarker of disease activity in IBD
For patients with inflammatory bowel disease (IBD), serum 25-hydroxyvitamin D (25[OH]D) may serve as a biomarker for disease activity, according to a study published online Sept. 10 in the Journal of Clinical Medicine.
Read original article on Medical Xpress - latest medical and health news stories →Related news
-
Experimental drug may reduce lymphedema swelling and scarring
United Kingdom
-
Women are and will be the predominant users of GLP-1 users, but research gaps remain critical
United Kingdom
-
Living environment and lifestyle factors may accelerate biological aging in early adulthood
United Kingdom
-
Late-pregnancy placental problems associated with higher ADHD risk
United Kingdom
-
New antibiotic combinations aim to achieve a lasting cure for persistent bacterial vaginosis
United Kingdom
-
Digital menstrual tracking risks creating more harm than benefit, argue experts
United Kingdom
-
Chewing tobacco linked to 251,000 deaths worldwide, with more than 90% of health loss concentrated in 10 countries
United Kingdom
-
Robotic hip and knee surgery fails to cut overall risk of repeat surgery
United Kingdom